Join us for a discussion about how combining a unified clinical trial data collection platform with intelligent automation can revolutionize drug development and why the current status quo is no longer sufficient. With novel capabilities, the industry can now explore new possibilities, such as incorporating additional sensors to identify surrogate or alternative endpoints, rethinking adaptive trial designs, and quickly responding to emerging data.

Medable is joined by Join GSK and Lightship for a panel discussion on how a trial platform as a service can enhance, expedite, and improve the day-to-day operations of clinical operations across the life cycle of a study.  

Uncover how to work with patients to shape everything from protocols to data collection.

‍

Katie madden, Digital & Process Optimization at GSK, joins Medable’s Andrew MacKinnon and Annie Hesslewood to discuss the importance of implementing a change management strategy coupled with a unified digital trial platform that streamlines eConsent, eCOA, sensors, and integration workflows into a single end-to-end experience.

In this panel discussion, industry experts from Uber Health, iXlayer, and Medable will discuss the rise in technology adoption has also raised the expectations of trial participants, who now seek simpler, more consumer-like experiences in clinical design.

Learn how sponsors and CROs can improve their clinical trial conduct by developing new strategies that create sustainable, repeatable, and effective clinical conduct.

Joe Dustin, VP/GM of eCOA and Annie Hesslewood, Site & Patient adoption lead at Medable host an open discussion with a panel of sites and CRAs to provide a candid assessment of how upcoming changes in the eCOA landscape can reduce burden on participants and sites to maximize the chance of success in clinical trials.

‍

Flo Mowlem, Senior Director, eCOA Science & Solutions shares insights on how electronic solutions, with a focus on patient-reported outcome (ePROs) can reduce burden on participants and sites to maximize the chance of success in oncology clinical trials.

‍

Experts from Medable, Syneos, and Pluto Health discuss how they have partnered to deploy patient-first digital trial solutions that leverage RWD, transforming it into actionable RWE insights for a sponsor client.

‍

Learn about the benefits of adopting consent management technology and best practices around developing change management and training programs to help sponsors, CROs and sites get the most out of eConsent.

‍

Watch the on-demand panel discussion between Medable, Syneos, Illingworth and Veeva, moderated by Gilead, as they discuss how the next generation of clinical development is now.

‍

Learn how to utilize digital data-flow designs in clinical trials to improve patient diversity and inclusion, increase operational efficiencies, enhance patient enrollment, engagement, and retention, and realize financial value.